Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Where Are They Now? Checking In With Four Alzheimer’s Disease Start-Ups

This article was originally published in Start Up

Executive Summary

Four start-ups previously profiled in START-UP – CoMentis, EnVivo Pharmaceuticals, Avid Radiopharmaceuticals and AC Immune SA – show how some biotechs have successfully ridden through the rough patches any company brave enough to tackle Alzheimer’s disease will likely face.

Advertisement

Related Content

Alzheimer's Dx: An Essential Piece of the Puzzle
Lilly To Cease Development Of Alzheimer's Drug
Elan's High Wire Act Finds a Semi-Safe Net
Molecular Origami: Start-Ups Tackle Protein Folding
Pfizer Sets New Biotech M&A Record
Avid Radiopharmaceuticals Inc.
AC Immune SA
EnVivo Pharmaceuticals Inc.

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC092198

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel